CANCER, HEART DISEASE, dementia, diabetes: In the lexicon of ageing and disease, these are some worrisome words. But researchers have suspected for years that all of these health issues, and more, have at their heart one common trigger: chronic low-grade inflammation. And now they may finally have proof.
In 2017, researchers in Boston reported on a clinical trial with more than 10,000 patients (mean age: 61) in 39 countries that tested whether an anti-inflammatory drug, canakinumab, could lower rates of heart disease. They discovered that it could, but they also found that it reduced lung cancer mortality more than 67 per cent, and reports of gout and arthritis (conditions linked to inflammation) also fell.
“Inflammation plays a role in everyone’s health,” says Dr Dana DiRenzo, a rheumatologist and instructor of medicine at Johns Hopkins University School of Medicine in Baltimore, USA. When inflammation levels increase, so does the risk of disease. But understanding inflammation can be tricky because, when you get a disease, inflammation levels naturally increase as your body fights the condition. Inflammation, in other words, is both good and bad.
When is inflammation a problem?
When you catch the flu and your body temperature rises to fight the virus, that’s a form of acute inflammation. So is the redness and swelling that occur when you sprain your ankle. The process is a temporary, helpful response to an injury or illness. It provides the healing chemicals and nutrients your body needs to repair the damage. Once the danger goes away, so does the inflammation.
Bu hikaye Reader's Digest India dergisinin October 2020 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Giriş Yap
Bu hikaye Reader's Digest India dergisinin October 2020 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Giriş Yap
ME & MY SHELF
Siddharth Kapila is a lawyer turned writer whose writing has focussed on issues surrounding Hinduism. His debut book, Tripping Down the Ganga: A Son's Exploration of Faith (Speaking Tiger) traces his seven-year-long journey along India's holiest river and his explorations into the nature of faith among believers and skeptics alike.
EMBEDDED FROM NPR
For all its flaws and shortcomings, some of which have come under the spotlight in recent years, NPR makes some of the best hardcore journalistic podcasts ever.
ANURAG MINUS VERMA PODCAST
Interview podcasts live and die not just on the strengths of the interviewer but also the range of participating guests.
WE'RE NOT KIDDING WITH MEHDI & FRIENDS
Since his exit from MSNBC, star anchor and journalist Mehdi Hasan has gone on to found Zeteo, an all-new media startup focussing on both news and analysis.
Ananda: An Exploration of Cannabis in India by Karan Madhok (Aleph)
Karan Madhok's Ananda is a lively, three-dimensional exploration of India's past and present relationship with cannabis.
I'll Have it Here: Poems by Jeet Thayil, (Fourth Estate)
For over three decades now, Jeet Thayil has been one of India's pre-eminent Englishlanguage poets.
Orbital by Samantha Harvey (Penguin Random House India)
Samantha Harvey became the latest winner of the Booker Prize last month for Orbital, a short, sharp shock of a novel about a group of astronauts aboard the International Space Station for a long-term mission.
She Defied All the Odds
When doctors told the McCoombes that spina bifida would severely limit their daughter's life, they refused to listen. So did the little girl
DO YOU DARE?
Two Danish businesswomen want us to start eating insects. It's good for the environment, but can consumers get over the yuck factor?
Searching for Santa Claus
Santa lives at the North Pole, right? Don't say that to the people of Rovaniemi in northern Finland